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ANOTACE 
Perorální podání je nejpohodlnější aplikace léčiv. Bohužel látky zejména bílkovinné 
nebo peptidické povahy nesnesou podmínky, které se v trávicím traktu vyskytují, navíc 
díky své velikosti se i velmi málo vstřebávají skrz střevní stěnu, tudíž je nutné je pro  
perorální podání speciálně upravit a chránit. Vhodnými kandidáty se jeví lipozómy – 
částice s fosfolipidovou membránou, které nejen že dokážou lipidy chránit před 
agresivním prostředím v GIT, ale navíc zlepšují jejich absorpci. Lipozómy lze připravit 
pomocí široké škály různých fosfolipidů, povrchově aktivních látek či solí žlučových 
kyselin.  
Cílem této práce bylo připravit lipozómy s přídavkem v praxi zřídka používaných 
surovin (konkrétně cholylsarcosinu, stearylaminu a d-α-tokoferol sukcinátu) a zjistit 
některé jejich povrchové vlastnosti, které jsou rozhodující pro další použití lipozómů. 
Lipozómy byly připravovány filmovou metodou a následnou hydratací a ruční extruzí 
přes membránu s definovanou velikostí pórů 200 nm. Jejich průměrná velikost poté 
byla stanovována pomocí foton – korelační spektroskopie (PCS). Podařilo se potvrdit, 
že velikost lipozómů je mimo jiné závislá na složení lipidové membrány, přidané 
substance svým nábojem nebo stavbou molekuly vedly ke zmenšení velikosti lipozómů.   
Další zkoumanou povrchovou vlastností byl zeta potenciál lipozómů. Podařilo se 
prokázat, že zeta potenciál úzce souvisí s nábojem použitých substancí, konkrétně u 
kladně nabitého stearylaminu byl naměřen kladný zeta potenciál, u záporně nabitého 
cholylsarkosinu zeta potenciál záporný. S touto problematikou souvisí i vliv pH 
použitého rozpouštědla na zeta potenciál lipozómů. Byl potvrzen předpoklad, že kyselé 
pH posouvá zeta potenciál směrem ke kladným hodnotám, pH bazické naopak 
k hodnotám záporným.  
Zkoumané substance tedy dodávají lipozómům podobné povrchové vlastnosti, jako 
substance již tradičně používané, ale před jejich větším rozšířením do praxe je nutné 
provést ještě další výzkum nejen jejich vlastností. 
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SUMMARY 
The most comfortable drug administration is the oral one. Unfortunately the protein or 
peptide substances are not stable in conditions present in the digestive system. Also, 
thanks to their size and polaritz they are very badly absorbed through the wall of the 
intestine so it is necessary to modify and specially protect them. Liposomes appear to 
be suitable candidates – particles with phospholipid membrane not only can protect 
peptides and proteins against the aggressive environment in the gastrointestinal 
system they also improve their absorption. Liposomes could be prepared of the wide 
scale of different phospholipids, surface active substances or bile acid salts.  
The aim of this research is to prepare liposomes with addition of rarely used 
substances in practice and substances (particularly cholylsarcosine, stearylamine and 
d-α-tocopherol polyethylene glycol succinate) and find out some of their surface 
properties crucial for the further use in liposomes. Liposomes were prepared by film 
method followed by hydration and manual extrusion through a membrane with 
defined pore size of 200nm. The average vesicle size was defined by the method of 
photon - correlation spectroscopy (PCS). We succeeded in confirmation that the 
liposome particle size is also dependent on the constitution of the lipid membrane, 
added substances lead to decrease of the size of liposomes due to their charge or the 
structure of the molecule.    
The next surface property examined was the zeta-potential of liposomes. We 
succeeded in confirmation that there is a close connection of zeta-potential with the 
charge of used substances. It was measured that in the liposomes with positively 
charged stearylamine the zeta-potential was positive and in the liposomes with 
negatively charged cholylsarcosine the zeta-potential was negative. The presumption 
of influence of the pH was also confirmed. Acid pH moves the zeta-potential values to 
positive and basic pH moves the values to the negative scale.  
The examined substances give the liposomes similar surface properties as usually used 
substances but before using them commonly further studies, not only of their 
properties, are needed. 
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1 INTRODUCTION 
The oral delivery is by far the most convenient route for drug delivery.  But, peptides 
and proteins are poorly bioavailable when administrated orally, mainly due to their 
mucosal permeability and lack of stability in the gastrointestinal environment, 
resulting in degradation of the compound prior to absorption. Therefore it is desirable 
to develop oral delivery systems, which can protect proteins from the harsh conditions 
of gastrointestinal tract (GIT) and thus also improve their absorption. Liposomal 
formulations offer the possibility of protection and absorption enhancement of poorly 
bioavailable drugs. Unfortunately, liposomes themselves are often unstable in GIT, e. 
g. In presence of acid, lipase and bile salts. It seems desirable to develop more stable 
liposomal formulations. Various lipo – and amphiphilic substances are used to stabilise 
the liposomal membrane. These compounds modify the properties of the liposomal 
membranes. To understand the in vivo behaviour of the liposomal formulations it is 
necessary to know about the interaction of special lipids or enhancers with normal 
phospholipid bilayers.  
The aim of the project was to examine with various methods the behaviour of several 
bioenhancers and special lipids in phospholipids membrane. So the concentration 
dependent influence of charged substances on the average and the zeta potential of 
the liposomes was investigated. 
The techniques used for this project were:  
- producing liposomes by the film method 
- forming liposomes by extrusion 
- photon correlation spectroscopy 
- measurement of zeta potential 
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2 THEORY 
2.1  What Is a Liposome 
An intense study in the liposome field began at the end of the 1960s, when liposomes 
were discovered, and has continued up to the present day. Liposomes help solve the 
problem of application of drugs of protein character into the body by other than 
parenteral routes. Thanks to research findings it is possible today to prepare liposomes 
of various sizes, various lipid composition, and with various surface characteristics, 
making it possible to satisfy different requirements on a peroral application or a 
targeted administration of medicines. The surface characteristics are determined by 
the choice of lipids forming the surface bilayer, and can be changed additionally by the 
covalent bond or the incorporation of glycoproteins, normal or synthetic polymers, 
sugars etc. In comparison with other medicinal carriers, liposomes are distinguished by 
their better biological degradability and relative toxicological and immunological safety 
[1]. 
Liposomes are generally spheric lipid bilayers of a 50 to 1000 nm diameter. They arise 
by the interaction of amphiphilic lipids in aqueous phase and they serve as an 
osmotically sensitive model membrane system, which is 105-times more permeable for 
anions than for cations [2].  
Figure 1 Schematic Illustation of liposome [3] 
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2.2  Classification of Liposomes 
Liposomes can be classified according to various criteria, such as size, lamellarity, lipid 
composition, application or name. The most frequent types of liposomes are 
summarised in Table 1 
2.2.1 Based on Size 
The size of liposomes plays an important role in their clearance. There is a difference in 
clearance between classical liposomes and sterically stabilised liposomes. With 
classical liposomes administered intravenously the clearance increases in conjunction 
with the size of the liposomes, because they are filtered out by the reticuloendothelial 
system [4].  
Sterically stabilised liposomes with average size around 250 nm are filtered out slowly 
by the Kupffer cells of the liver. With liposomes sizing 300 nm the filtering by the 
spleen cells is increased, presumably by a passive filtration mechanism. Thus, by the 
preparation of liposomes with a defined size (by sonication or extrusion) the control of 
the circulation time of liposomes and an increased extravasation can be reached. 
By peroral application the particles are absorbed in the intestinal. Generally, 
nanoparticles have relatively higher intracellular uptake compared to microparticles 
and are available to a wider range of biological targets due to their small size and 
relatively mobility. Many studies regarding size effects on nanoparticle absorption by 
intestinal epithelia have been performed using polystyrene standard particle 
suspensions of defined size distributions. Particle with mean diameters of 50 or 100 
nm showed a higher uptake in the rat intestine then larger particles [5]. Particles < 100 
nm show higher rates of uptake by absorptive enterocytes than particles > 300 nm. 
The uptake of particles < 100 nm by the follicle – associated epithelia is more efficient 
than uptake via absorptive enterocytes. Uptake of particles > 500 nm by absorptive 
enterocytes is an unlikely event and only particles < 500 nm reach the systematic 
circulation. The uptake of 100 nm particles in the rat intestine was significantly 
increased compared to larger particles of 1 – 10 µm. Nearly identical uptake rates were 
observed in Peyer’s patch regions and enterocytes for 100 nm particles, while particles 
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> 100 nm were only observed in the Peyer’s patches. As a rule of thumb, size < 500 nm 
will be required for optimal uptake and bioavailability [6].     
2.2.2 Based on Circulation Time in vivo 
Conventional Liposomes 
Liposomes of a very simple structure are labelled conventional or classical 
liposomes. Their main subpart is egg phosphatidylcholine – EPC and cholesterol in 
various amounts. Cholesterol is added for the increase of liposome stability in the 
presence of plasma and for the increase of the fluidity of the membrane, whereby 
is minimised the drug leakage.The negative charge is important for aggregation 
blocking. These liposomes are recognized by phagocytic cells of the 
reticuloendothelial system, they are eliminated from the circulation quite quickly, 
their half-life falls with the growing radius, negative surface charge and fluidity [7].  
 
Table 1 Classification of liposomes [1] 
According to size 
Small unilamellar vesicles 
Large unilamellar vesicles 
Large multilamellar liposomes 
According to circulation in vivo 
Classical or convention liposomes 
Sterically stabilised liposomes 
According to lamellarity 
Unilamellar 
Multilamellar 
According to application 
Diagnostic 
Therapeutic 
According to surface charge 
Cationic/ DNA vector 
Anionic 
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Neutral 
Specialised liposomes 
Targeted liposome 
Immunoliposome 
Transferosome 
Liposomal DNA vector 
 
 
Sterically Stabilised Liposomes 
By the addition of specific mixtures to the classical liposomes it is possible to 
gain liposomes with greater stability in biological fluids and lesser reactivity to plasma 
proteins and cell surface receptors. First surveys were made with the use of GM1 
gangliosid, phosphatidyl inositol (PI), dipalmitoyl phosphatidylcholine (DPPC) or 
distearoyl phosphatidylcholine (DSPC) [8].  
Later, polyethylen glycol (PEG) was used and appeared more efficient than 
gangliosids or PI. Today, PEG is used also in the form of fatty acids ester. 
From the 1990s, bipolar or bolaamphiphile ether lipids are used for the purpose 
of liposomes stabilization; they have unique qualities and are obtained from the cell 
walls of Archaebacteria. These liposomes are then called archeosomes. Some types of 
Archaebacteria live in extreme conditions of vulcanic hot springs, salt lakes or places 
with high basic or acidic pH (e.g. Thermoplasma acidophilum). From the cell walls of 
these bacteria we can gain lipids from which we can prepare liposomes more resistant 
to low pH in the stomach (this is important for the peroral application of liposomes).  
 
2.2.3 Based on Lamellarity 
Small Unilamellar Vesicles (SUVs) 
Small Unilamellar Vesicles have a radius smaller than 50 nm and have only one lipid 
bilayer. They are prepared by sonication or extrusion. The size of SUVs depends on the 
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lipids used, the preparation temperature and the length of sonication.  Generally these 
are metastable liposomes, which tend to connect into larger unilamellar vesicles.  
Large Unilamellar Vesicles (LUVs) 
Large Unilamellar Vesicles have a radius of 100-2000 nm and again only one lipid 
bilayer. They can be prepared either by calcium-induced fusion, sonication of SUVs, or 
by extrusion through defined pore-size filters. By this method, LUVs of a given size can 
be prepared. The internal capacity of these liposomes is quite high, therefore they 
appear to be the most suitable liposomes for the protection of big protein molecules 
of pharmaceuticals.  
Large Multilamellar Vesicles (LMVs) 
Large Multilamellar Vesicles arise spontaneously if the bilayer-forming lipid mixture is 
hydrated in a large amount of water or buffer. However, liposomes of very different 
sizes (from 0.5 to 10 µm), with different lamellarity and different internal capacity, are 
produced in this way. LMVs with a given size can be prepared by a careful extrusion 
through defined pore-size filters with soft pressure. Nevertheless, even these LMVs 
differ in size and the number of individual inner compartments. The overall internal 
capacity of a LMV is quite large, but the space in the individual compartments is too 
small to accommodate large medicinal proteins. LMVs are therefore used most often 
as a model membrane system for the monitoring of membrane systems qualities, their 
susceptibility to hydrolysis by phopholipases, etc. [9].  
 
2.2.4 Based on Surface Charge 
On their surfaces, liposomes may carry either a positive or a negative charge that is 
supplied mainly by admixtures to normal lipids (EPC and cholesterol) because the 
charge of these classic liposomes is in essence neutral. It is not a problem to prepare 
liposomes with a substantial negative or positive charge. However, from a practical 
point of view, the positively charged liposomes are mainly of a big importance. 
Liposomes with a positive charge are sometimes called liposomal DNA delivery vectors, 
as they can be used for a transport of DNA right in cancer cells. Therefore, it is also 
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possible to include cationic liposomes into the specialized liposomes, as liposomes 
represent one of the safest and most universal transfer vectors of today’s. The cationic 
lipid is mixed with the membrane – destabilising lipid - dioleoyl 
phosphatidylethanolamine (DOPE) - in approximately equimolar ratio. DOPE 
destabilises the membrane of the target cell and the DNA is released into the 
cytoplasm [10].  
The liposomes with the surface charge are removed faster than the classical ones. The 
negative charged are trapped mainly by the splenic uptake, which is about twice faster 
than for the positively charged liposomes. On the other hand, cationic liposomes are 
trapped up to four times faster by the brain uptake and lung tissue than the anionic 
ones [11].  
 
2.2.5 Specialised Liposomes 
Targeted Liposomes are liposomes that are routed straight to recognition and direct 
continuation on specific cells in vivo. This is achieved by incorporation of a specific 
ligand into the surface layer of the liposome. The half-life of the ligand should be 
roughly the same as that of the liposome itself; moreover, the liposome should not 
decrease it. If the surface ligand is an antibody, the liposomes are called 
Immunoliposomes. The clearence of classical liposomes with surface antibodies is very 
fast: it endures only a few minutes in circulation, whereas the half-life of 
Immunoliposomes prepared from sterically stabilised liposomes is in orders of hours. It 
follows that Immunoliposomes are prepared mainly from sterically stabilized liposomes 
[12].  
 
2.2.6 Clinical Applications 
2.2.6.1 Diagnostic 
Big liposomes are trapped quickly by phagocytic cells of the reticuloendothelial system 
(RES). This fact is used for transport of diagnostic imaging agents into the liver and 
spleen. The aqueous contrast-enhancing agents are closed into liposomes that are 
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inserted to the body and, after some time, the differences between healthy and 
tumorous tissue are displayed by computer tomography [13]. The liposomes are filled 
not only with substances soluble in water but also with gas. These liposomes are of a 
big importance for diagnostics by ultrasound waves or by magnetic resonance. In these 
methods, the principle of the liposomes’ use is the varying magnetic susceptibility and 
the ability to reflect the sound waves. Lipids of these liposomes are enriched mostly 
with components supporting the stability of liposomes (for example, dipalmitoyl 
phosphatidylcholine or distearoyl phosphatidylcholine).  
 
2.2.6.2 Therapeutical Application 
Localised/Regional Use 
The topical application of liposomes has a big potential mainly in dermatology and 
transfers from this field also to the commercial sphere of pharmaceutical companies 
and the cosmetic industry. In this area, the main asset of liposomes lies in the fact that 
they open a possibility to transport hydrophilic substances into the deep layers of the 
skin (right to Stratum Corneum), which was earlier impossible. Moreover, liposomes 
are absorbed to the skin relatively quickly thus the duration of the effective 
substance’s exposition on the skin’s surface is decreased as well as the danger of their 
wipe still before their absorption. Furthermore, liposomes are trapped selectively by 
hair follicles. This quality allows transporting melanin, proteins, genes or little 
molecules directly into the hair follicle; thereby it is possible to accomplish the local 
genetic therapy that may restore the hair growth, the old hair pigment or to slow the 
untimely loss of hair [14].     
Systemic Application  
Liposomes in the systemic application of medications are put into effect in treatment 
of many diseases and an intensive research is in motion in many other areas. The main 
advantage of liposomes is the decrease in the systemic toxicity of medications that are 
transported directly into the effective place by the liposomes. Furthermore, liposomes 
protect the drug itself from the aggressive influences of the environment into which it 
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is applied; they conceal the medication from the cells of the immune system. 
Therefore, there is a wide range of liposomes’ use that is also permanently increasing.  
Liposomes are used in the treatment of cancer already for many years mainly because 
of their ability to decrease the systemic toxicity of these medications and to increase 
their circulation time and effectiveness in the place of desired action. For example, 
doxorubicin closed into polyethlylen glycol coated liposomes has a better 
pharmacokinetic than doxorubicin itself. This formulation is used as an alternative to 
the standard treatment of Karposi’s Sarcoma [15].  
Liposomes are used also for the treatment of asthma. The medications closed into the 
liposomes – that are applied in the aerosol form – are more effective during the 
relieving bronchial constriction than the medications applied without the liposomes.  
Liposomes find their use also for the treatment of arthritis. The absorption and 
distribution of prednisolon applied by injection in liposomes and of the free steroid in 
mice have been compared. Liposomal prednisolon was found to be retained by the 
injected tissue for longer periods of time [16].   
Great hopes with reference to liposomes are rested on the treatment of diabetes by 
using perorally applied insulin. The insulin in the form of spray dried insulin applied in 
an aerosol form was already launched in the market, but, unfortunately, the results in 
the clinical praxes did not live up to the expectations. It would be possible to write 
many pages about the advantages of peroral application of insulin over that by 
injection, but what is important may be the fact that the ideal liposomes for peroral 
application have not yet be found although the research on this problem solving is 
really intensive.  
 
        
2.3  Photon Correlation Spectroscopy (PCS) 
Photon Correlation Spectroscopy (sometimes referred as Dynamic Light Scattering or 
Quasi – Elastic Light Scattering) is a technique for measuring the size of particles 
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typically in the sub micron region. Therefore, it is useful for the determination of 
liposomes’ size. As mentioned above, the size of liposomes is one of their most 
essential characteristics, as its knowledge helps us to estimate the fate of the liposome 
in the organism: how long the liposome will probably be in circulation until it will be 
caught by the cells of the RES. The knowledge of the liposome’s size also offers the 
possibility to estimate its inner volume. Finally yet importantly, the fast measuring of 
the liposome’s size offers a control whether or not a fault was committed during their 
production, which is usually the extrusion through defined pore-size filters, or whether 
the membrane was intact etc.    
There exist some methods how the size of liposomes may be found. The former is PCS 
mentioned above; the next are the electron microscopy, field flow fractionation or 
atom force microscopy. However, it is PCS that is used massively. What are the 
reasons? 
 PCS is a very fast method: the sample measurement itself lasts about 10 
minutes. If we add the time needful for the preparation of the sample in the 
case of the electron microscopy, we get the time in the order of hours. 
 
 In the case of PCS, liposomes are measured in their natural state while during 
electron microscopy, it is necessary to dehydrate the sample in a complicated 
way or to stain it and then to use a difficult freeze fracture technique.     
 
 PCS measures a distribution of tens up to thousands of particles. The electron 
microscopy needs hundreds of photos for a comparable analysis [17].  
  
2.3.1 Principle of PCS 
PCS measures the Brownian motion of particles and correlates it with their size. The 
Brownian motion is a random movement of particles caused by the collisions with the 
molecules of the solvent they are surrounded by. The big particles move slower, while 
the small ones faster. The dimension of the Brownian motion is measured by the 
diffusion of the ray of light that passes through the suspended sample. This dimension 
19 
 
is expressed as so called translational diffusion coefficient (usually given the symbol D). 
The diameter of the particles is then calculated by the Stokes-Einstein equation: 
 
Where:  d(H) = hydrodynamic diameter 
  D = translational diffusion coefficient 
  k = Boltzmann’s constant 
  T = absolute temperature 
  η = viscosity 
The hydrodynamic diameter that is gained from this method corresponds to the 
diameter of a sphere with the same translational coefficient. During the measuring, it 
is necessary to keep the same temperature, as the viscosity of the liquid is dependent 
right on the temperature. 
 The translational diffusion coefficient is not dependent only on the size of the particle 
“core”, but also on the surface structure of the particle and on the concentration and 
type of ions in medium [18].  
 
2.3.2 Factors Affecting Diffusion Speed of Particles 
Ionic Strength of Medium 
The ions in the medium and total ionic concentration can affect the particle diffusion 
speed by changing the thickness of the electric double layer called the Debye length  
(κ-1). Hence even a low conductivity medium can extend the double layer of ions 
around the particle, decreasing diffusion speed and increasing hydrodynamic 
diameter. Conversely, higher conductivity media suppress the electric double layer and 
the measured hydrodynamic diameter. 
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Surface structure 
Some changes of surface structure can induce a change of particle diffusion speed, 
which however does not correspond to the change of its size. An adsorbed polymer 
projecting into the medium reduces diffusion speed more than a polymer adsorbed 
directly on the surface of the particle. Nature of the surface and ionic speed of the 
medium may also influence polymer conformation, changing the apparent particle size 
by a few nanometers.  
Non – spherical particles 
All techniques for establishing the size of a particle encounter a problem – how to 
describe a non – spherical particle? Different techniques are sensitive to different 
particle properties – e.g. projected area, density, scattering intensity – and therefore 
produce different size distributions for any measured sample. It is important to note 
that none of these results is completely accurate. The measured hydrodynamic 
diameter of a particle corresponds to the hydrodynamic diameter of a sphere with the 
same translational diffusion coefficient. 
 
2.3.3 Optical Configuration of the PCS Instrument 
A typical PCS system consists of six parts (see Figure 2). The laser 1 is the light source 
used to illuminate the sample enclosed in the measurement cell 2. The scattered light 
is then captured by the detector 3, and rotated against the incoming laser beam by 90 
or 173 degrees or specific angle (according to different instrument types). The intensity 
of the scattered light must fall into a certain range in order for the detector to measure 
it correctly. Should the intensity be too high, the detector would be saturated and the 
results very inaccurate. The laser source, and consequently the dispersion of light, is 
regulated by the attenuator 4. The scattering intensity of the signal is then relayed to 
the correlator 5. The correlator compares the scattering intensity at successive time 
intervals to derive its rate of variation. Data from the correlator are passed on to the 
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computer 6 to be analysed by a special software that calculates on their basis the size 
of the particles in the sample [19].  
Figure 2 Optical Configuration of PCS Instrument [20]  
 
 
 
2.4  Zeta Potential 
Zeta potential is the charge that a particle (e.g. a liposome) acquires when suspended, 
usually in a water-type medium. It is however not the charge on the surface of the 
particle, but rather on the surface of its solvation shell. Knowledge of the zeta 
potential enables estimating the fate of the liposome in the organism, i.e. how quickly 
it will be marked by proteins in blood plasma that speed up its capture by the RES. This 
phenomenon can be partly slowed down by masking the surface of the liposome with 
a suitable polymer, such as polyethylene glycol (PEG). PEG not only creates a steric 
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barrier against binding of the plasma proteins on the liposome, but also changes its 
zeta potential [21].  
But how is charge generated on the surface of an apparently neutral particle? The 
cause is the nature of the particle surface and the properties of the medium in which it 
is dispersed. One of the mechanisms is the ionisation of surface groups. Dissociation of 
acidic groups on particle surface leads to a negative surface charge. Conversely, 
dissociation of basic groups delivers a positive charge. The size of this charge depends 
on the acidic or basic strengths of the surface groups, and on the pH of the medium. 
Surface charge can also be generated by adsorption of ions or ionic surfactants on the 
surface of the particle. Cationic surfactants provide the particle with a positive charge, 
anionic surfactants with a negative one [22].  
The existence of electric charge on the surface of the particle then affects the position 
of ions in the medium in the immediate neighbourhood of the particle. Ions with the 
opposite charge converge around the particle and create the electrical double layer 
surrounding it. This layer of liquid around the particle can be ideally divided into two 
parts: The inner Stern layer, in which the ions are firmly bound, and the outer diffuse 
region, where the bond is much weaker. It is possible to find an imaginary boundary in 
the diffuse region within which the ions and the particle make up a stable entity. When 
the particle moves, the ions within this boundary move along with it. The potential on 
this boundary (the slipping plane) can be measured and is called zeta potential [23].  
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Figure 3 Schematic representation of zeta potential [24] 
 
  
2.4.1 Factors Affecting Zeta Potential 
pH 
The pH is one of the most important factors affecting the zeta potential in water 
solutions. A value of zeta potential without acknowledgement of the pH at which it 
was measured is a completely meaningless number. The same sample will exhibit 
different zeta potentials when measured at different pH values. Basic solutions shift 
the zeta potential of the dispersed particles towards negative values, whereas acidic 
solutions shift it towards positive values. The pH value corresponding to a zeta 
potential of zero is called the isoelectric point. It is the least stable state of the colloid 
system (widely applied in colloid system technologies). 
Conductivity 
Thickness of the electrical double layer (Debye layer, κ-1) depends on the concentration 
of ions in the medium, and can be calculated from its ionic strength. The higher the 
ionic strength, the lower it compresses the electrical double layer of the particle. 
Inorganic ions can react with the charged surface of the particle principally in two 
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ways. Either through non – specific ion adsorption, which does not affect the 
isoelectric point, or through specific ion adsorption, which induces a change of the 
isoelectric point. Specific ion adsorption on the surface of the particle, even in low 
concentration, can have a dramatic effect on the zeta potential [22].  
 
2.4.2 The Principle of Measurement of Zeta Potential 
Measurement of zeta potential is based on electrophoresis. When we apply an electric 
field to an electrolyte with suspended charged particles, the particles are attracted 
towards the electrode with the opposite charge. Viscous forces of the liquid act against 
this movement. When an equilibrium between these forces is reached, the particles 
move with a constant velocity. This velocity depends on the strength of the electric 
field (or voltage gradient), on the dielectric constant of the medium, on the viscosity of 
the medium, and on the zeta potential. The velocity of a particle in a unit electric field 
is referred to as its electrophoretic mobility. Its zeta potential is then calculated from 
its electrophoretic mobility by Henry’s law.  
 
Where: UE = electrophoretic mobility 
  Z = zeta potential 
  ε = dielectric constant 
  η = viscosity 
  f(κa) = Henry’s function  [25] 
2.4.3 Optical Configuration of the Zeta Potential Instrument 
A typical instrument for measurement of zeta potential consists of 6 parts (see Figure 
4). The laser 1 is the source of a beam of light. The beam illuminates the sample in the 
measurement cell 2. Scattered light is detected in the angle of 13 degrees 3. Intensity 
of the scattered light must be in a certain range for the detector to measure it 
correctly. This is achieved by the attenuator 6 that regulates the light beam generated 
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by the laser. Light dispersion is proportional to the velocity of the moving particles. 
This information is passed on to the digital signal processor 4 and further to the 
computer 5. A special computer software calculates from the values thus obtained the 
value of the zeta potential of particles in the sample. Sometimes compensation optics 
7 are also included for correction of dispersant refraction and of errors generated by 
the walls of the measurement cell. 
Figure 4 Optical Configuration of Zeta Potential Instrument 
 
 
2.5 Materials for Liposomes 
2.5.1 Eggs phosphatidylcholine (EPC) 
Eggs phosphatidylcholine belongs to the group of phospholipids that is part of lecithin. 
Phospholipids are the essentials components of all cell membranes. The molecules of 
phospholipids are amphiphilic that means they have both polar and non-polar parts. 
The non-polar (hydrophobic) part of the EPC molecule is formed by two chains of fatty 
acids. These form esters in the first and the second position of the glycerol backbone. 
The polar (hydrophilic) part of the molecule is formed by the ester of choline and 
phosphate in the third position of the glycerol molecule (see Figure 5). In aqueous 
solution, at a specific concentration and temperature the EPC is able to form lamellas, 
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micelles or liposomes spontaneously. The most advantageous for pharmacy is that EPC 
is essentially non-toxic, it doesn’t provide any contraindications or interactions with 
other drugs, and it is not mutagenous and can’t be overdosed.   
Figure 5 Molecule of EPC [26] 
 
 
2.5.2 Cholesterol (Chol) 
Incorporation of cholesterol in liposome bilayer can bring about big changes in the 
preparation of these membranes. It does not mean that it forms bilayer membrane 
structure by itself, but can be incorporated into phospholipid membrane in very high 
concentration up to 1:1 or 2:1 molar ratios of cholesterol to phosphatidylcholine. 
Being an amphiphilic molecule, cholesterol inserts into the membrane with its hydroxyl 
group oriented towards the aqueous surface and aliphatic chain aligned parallel to the 
acyl chains in the centre of the bilayers and also it increases the separation between 
choline head groups and eliminates the normal electrostatic and hydrogen bonding 
interactions. Cholesterol increases the fluidity of liposomal membrane [27]. 
Figure 6 Molecule of cholesterol 
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2.5.3 Stearylamine (SA) 
In systematic nomenclature is SA called 1-aminooctadecane. It is a fatty amine and 
cationic surfactant. SA is used in liposome preparation because it causes the liposomal 
surface to be positively charged. Cationic liposomes are important as DNA vectors.  In 
addition, these particles are not being removed from the circulation so quickly in 
comparison to anionic liposomes.  SA increases the liposomal stability in mild acidic or 
basic environment. However these liposomes are not resistant to destruction by bile 
acids and low pH level present in digestive system, so SA does not solve the problem of 
oral administration of liposomes [28]. Nevertheless, it was proved that SA decreases 
effectively the leaking of cationic drugs from liposomes so it is suitable for liposomal 
drug formulation [29]. The low price within the group of cationic surfactants is its main 
advantage but on the other hand it is quite toxic. In higher concentrations, it causes 
skin, eye and respiratory system irritation and destroys mucosa membranes.  
Figure 7 Molecule of SA 
 
 
2.5.4 Cholylsarcosine (CS) 
CS could be described as N – methylglycine conjugated to a cholic acid. It is a non-toxic 
bile salt derivative that is the absorption enhancer. CS is comparable to conventional 
bile acids that are potentially carcinogenic. CS could be used to increase absorption of 
peptide drugs after oral administration (e.g. insulin, calcitonine) because it forms 
complex compounds with calcium ions. These cause the decrease of tightness of tight 
junctions that causes the increase of permeation and absorption of peptides [30]. It is 
absorbed in a negligible amount from the small or large intestine so the long time 
administration induces chances neither in biliary lipid composition nor liver function. It 
is able to form micelles in the solutions of critical micellar concentration [31]. CS could 
form lipophilic ion – pair complexes with different organic cations in liposomes that 
also increases the permeability of cations through biological membranes [32]. In 
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human medicine CS could be used in bile salt replacement therapy of short bowel 
syndrome [33]. 
Figure 8 Molecule of CS [31] 
 
 
2.5.5 Vitamin E TPGS NF (TPGS) 
In systematic nomenclature it is called d-α-tocopheryl polyethylene glycol 1000 
succinate. It is a derivative of vitamin E soluble in water. By its structure the compound 
has an amphiphilic character that means it contains a polar head that consist of 
polyethylene glycol and a lipophilic tail composed by tocopherol succinate. The 
amphiphilic character of the compound causes that TPGS could form micelles if its 
concentration in the solution exceeds the critical micellar concentration. TPGS is a 
surface active compound so it could be used as an emulsifier, a solubiliser, an 
absorption enhancer or water – soluble source of vitamin E. Sokol a kol. [34] clinically 
demonstrated that TPGS could increase the absorption of highly lipophilic cyclosporine 
during the immunosuppressive therapy in patients after the organ transplantation. 
TPGS belongs to the non-ionic surfactants, which are more hydrophobic than the ionic 
ones. These provide bigger capacity for solubilisation of poorly soluble drugs and are 
less toxic to biological membranes. These also influence the cellular drug transport 
activity especially by the inhibition of efflux pumps (i.e. P – glycoprotein) [35]. When 
TPGS is used in liposomes the stability is being better because polyethylene glycol 
decreases liposomal aggregation [36]. The quite low price is a not negligible merit 
within commonly used phospholipids with PEG chain.  
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Figure 9 Molecule of TPGS [37] 
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3 PRACTIC PART 
3.1  Material 
d – alpha tocopheryl polyethylene glycol   Eastman, UK 
1000 succinat – Vitamin E TPGS NF (TPGS)   
Distilled water IPMB, Germany 
Egg phosphatidylcholine (EPC) Lipoid, Germany 
Chloroform (CHCl3) VWR Prolabo, EC 
Cholesterol (Chol) Synopharm GmbH, Germany 
Cholylsarcosine (CS) Prodotti Chimici e Alimenteri 
S.p.A., Italy 
Methanole - HiPerSolv Chromanorm (CH3OH) VWR Prolabo, EC 
Potassium chloride (KCl) AppliChem, Germany 
Potassium phosphate (KH2PO4) J. T. Baker, Holland 
Sodium chloride (NaCl) Wassex House, UK 
Sodium phosphate dihydrate (Na2HPO4 · 2 H2O) J. T. Baker, Holland 
Stearylamine (SA) Sigma Aldrich, Germany 
 
3.2 Equipment 
Extrusion 
Extrudor – LiposoFast Basic Avestin Europe GmbH, Germany 
Membranes – Polycarbonate membrane, diam. = 19mm, Avestin Europe GmbH, Germany 
pore diam. = 200 nm  
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PCS 
Zetasizer 3000 HS Malvern Instruments GmbH, 
Germany 
Software – PCS, ver. 1.61 Malvern Instruments GmbH, 
Germany 
Cuvette – Einmal – Küvetten aus Polystyrol; 4.5 ml; Carl Roth GmbH, Germany  
4 klare Seiten 
Membrane filter - Rotilabo® - Spritzenfilter, steril, 0.22 µm Carl Roth GmbH, Germany 
Zeta – potential 
Zetasizer 3000 HS Malvern Instruments GmbH, 
Germany 
Software – PCS, ver. 1.61 Malvern Instruments GmbH, 
Germany 
Membrane filter - Rotilabo® - Spritzenfilter, steril, 0.22 µm Carl Roth GmbH, Germany 
 
3.3 Preparing of liposomes, film method 
3.3.1 Film formation 
For the preparation of liposomes whose membrane is composed of diverse lipids, 
it is necessary to dissolve individual lipids first in an organic solvent. As an organic 
solvent, a mixture of chloroform and methanol in 9:1 ratio was used. The final lipid 
concentration was 10 µmol/ml. The lipid solutions were then mixed in a glass vial 
of 5 ml volume, according to the desired ratio of individual lipids in the prepared 
liposomes, so that the final total lipid amount was 10 µmol. Then, the organic 
solution was vaporized in a water bath heated to 50 °C, either by nitrogen stream 
or under vacuum. After the evaporation of solvent, a film of lipid mixture was 
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formed on the vial wall. Possible solvent residues were thoroughly evaporated in 
an exsiccator under vacuum, where the vial was left for one hour.  
3.3.2 Hydration 
A magnetic stirrer, a few glass beads and 1 ml of buffer were added to the dry film 
in the vial. As buffer, phosphate buffered saline (PBS; pH 7.4; sterile filtrated 
through a 0.22 µm filter; with the following composition: 8.0 g NaCl + 0.2 g KCl + 
1.44 g Na2HPO4 x 2H2O + 0.2 g KH2PO4 + H2O ad 1000 ml) was used. The mixture 
was stirred with a magnetic stirrer for 30 minutes using the maximum velocity, 
unless the whole of the film was suspended in the buffer.  Before the very 
extrusion, the suspension was left inactive for at least 30 minutes.  
3.3.3 Extrusion 
The extrusion was performed using the LiposoFast-Basic extruder (see Figure 10). 
Between the cylinders of the extruder, a membrane with pore size 200 nm is 
inserted, through which the lipid suspension is extruded.  Each sample was 
extruded 41-times. After the extrusion, the suspension of large unilamellar 
liposomes was stored in Eppendorf cups. Before performing next tasks, the 
liposomes had to be left inactive for at least 30 minutes.  
Figure 10 LiposoFast-Basic [38] 
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3.4 Photon correlation spectroscopy 
3.4.1 Sample preparation 
The size of liposomes and the polydispersity of the sample was measured with a 
Zetasizer 3000HS. The samples were measured in cuvettes of 4.5 ml volume, made 
of polystyrene and having 4 pellucid walls.  The sample was diluted by PBS, so that 
the final concentration of the sample counted 100 – 200 kilo counts per second 
(Kcps = collected photons per second divided by one thousand). This 
concentration was usually reached with dilution 1:200, or eventually 1:100. Before 
the buffer was used, it was filtered through a sterile filter with pore size 0.22 µm. 
The measuring was carried out at 30 °C, the intensity of the scattered light was 
measured under a 90° angle, the wavelength of the laser beam was 633 nm, and 
the refractive index of the PBS was 1.3357. 
3.4.2 Model results 
During a single measuring, each sample was measured 30-times. For each of the 
three tens, the software provided a single average, that is three averages for the 
whole measuring. From these three averages, the final average was calculated. As 
the results of each average, the software provided data about kilo counts per 
second, z – average and polydispersity (PI). The Z – average is the intensity 
weighted mean size of the particle population. The polydispersity is a parameter, 
which indicates the width of the distribution. For strongly monodisperse 
populations it is under 0.1, a polydispersity under 0.2 still indicates a 
monodisperse distribution. From the given data, the software projected also the 
graph of the particle size distribution in the sample (see Figure 11). 
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3.5  Zeta potential measurement  
3.5.1 Sample preparation 
Zeta potential was measured again with Zetasizer 3000HS. It was necessary to 
dilute the samples before the measuring, so that the final concentration would 
count 1000 – 2000 kilo counts per second, which usually matches 1:30 dilution. 
Before the buffers were used, they were filtered through a sterile filter with pore 
size 0.22 µm. With all samples, the measuring was made in three buffers – in PBS, 
pH 7,4 (for the composition see 3.3.2 Hydration), in a  phosphate buffer (PTP, pH 
7.0; composition: 0.534 g Na2HPO4 x 2H2O + 0.272 g KH2PO4 + H2O ad 1000 ml) and 
in a distilled water. The measuring was carried out under 30 °C in a capillary cell.  
3.5.2 Model results 
Within a single measuring, each sample was measured 10-times. The software 
then calculated the average zeta potential of the individual measurings. Most 
important were the data about kilo counts per second and Zeta in mV. From the 
data, the software projected a graph of zeta potential distribution in the sample 
(see Figure 12). 
Figure 11 PCS software, results of measure 
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Figure 12 Zeta potential software, results of measurement 
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4 RESULTS and DISCUSSION 
Size of each liposome was measured using PCS and zeta potential. All liposome types 
were prepared at least three times. The data were then averaged and arranged in 
tables and charts.  
4.1 EPC:SA:Chol  - liposomes 
Table 2 EPC:SA:Chol - liposomes, results 
Liposomes SA [%] Z ave [nm] Poly 
Zeta [mV] 
in PBS in PTP in H2O 
EPC:Chol 1:1 0.0 274.6 0.117 -3.9 -8.6 -10.4 
EPC:SA:Chol 10:1:9 5.0 267.5 0.100 10.7 24.0 54.8 
EPC:SA:Chol 15:2:13 6.6 287.7 0.163 12.6 32.8 48.0 
EPA:SA:Chol 5:1:4 10.0 255.3 0.069 19.3 37.8 47.7 
EPC:SA:Chol 7:2:5 14.3 227.6 0.106 23.0 41.5 56.3 
EPC:SA:Chol 2:1:1 25.0 187.3 0.079 28.5 53.3 57.9 
EPC:SA:Chol 10:7:3 35.0     38.2 46.1   
 
Graph 1 EPC:SA:Chol - liposomes, zeta potential 
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Liposomes prepared by extrusion through a membrane with 200 nm pores containing 
only EPC and Chol (in 1:1 ratio) had an average size of 274.6 nm. Due to the relatively 
high Chol content, the liposomal membrane was more fluid and the liposomes were 
larger than the pores of the membrane. After adding SA to the lipid mixture, extrusion 
through a membrane with the same pore aperture yielded liposomes of sizes between 
267.5 nm (at 5% SA) and 187.3 nm (at 25% SA). The decreasing size can be explained 
by the falling Chol content, but also by the impact of SA, which prevents aggregation of 
liposomes due to its positive charge. The high intermolecular interactions of the 
stearylgroups increase the membrane rigidity and therefore reduce the size of the 
liposomes.  
Measurement of zeta potential revealed that SA lends, due to its positive charge, the 
liposomes a positive zeta potential. This happens even at neutral pH (the 
measurements were carried in PBS of pH 7.4 and in PTP with pH 7.0). Water is not 
suitable as a medium for zeta potential measurements, as it has a low buffer capacity. 
This seems to have happened during measurements of the zeta potential of water-
based liposomes at 35% SA content, which yielded completely meaningless values. 
Data from zeta potential measurements in the other two buffers were more 
significant. It was possible to confirm that zeta potential rises with the rising SA 
content in the liposomes. The zeta potential of SA-free liposomes was –3.9 mV in PBS 
and –8.6 mV in PTP. Adding SA to the mixture gradually increased the zeta potential, 
reaching 38.2 mV in PBS (35% SA) and 53.3 mV in PTP (25% SA). It was impossible to 
produce liposomes with even higher SA ratio through manual extrusion. 
Increase of zeta potential upon addition of SA into a mixture of lipids was also 
observed by Biruss and Valenta [39], who measured the zeta potential of the liposome 
mixture DPPC1:Chol (7:2) 1.42 mV, and of the mixture DPPC:SA:Chol (7:2:2) 55.03 mV. 
The same study also investigated change of liposome parameters upon addition of 
progesterone. The above-mentioned liposomes then exhibited zeta potentials of 7.54 
mV and 49.97 mV, respectively. Unfortunately, the authors did not mention the pH 
and buffers of their measurements. Liposomes with negative zeta potentials showed 
even larger differences after addition of progesterone. This favours the conclusion that 
                                                        
1 DPPC = 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine 
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both the composition of the lipidic bilayer and of the interior of the liposome effect 
the zeta potential, because the substances of the interior can go in the exterior buffer 
and influence the zeta potential.  
Zschöring and others [40] have shown that in liposomes of the EPC and SA 
composition, zeta potential increases sharply with the SA content only up to 20mol% 
of SA. Higher concentrations of SA cause saturation of zeta potential, which doesn’t 
increase substantially afterwards. These measurements were carried out in a buffer 
with pH 7.4 and of the composition 3 mM HEPES + 0.1 M NaCl + 0.05 mM EDTA.  
 
4.2 EPC:CS:Chol – liposomes 
Table 3 EPC:CS:Chol - liposomes, results 
Liposomes CS [%] Z ave [nm] Poly 
Zeta [mV] 
in PBS in PTP in H2O 
EPC:Chol 1:1 0.0 274.6 0.117 -3.9 -8.6 -10.4 
EPC:CS:Chol 10:1:9 5.0 196.4 0.065 -3.7 -4.8 -7.2 
EPA:CS:Chol 5:1:4 10.0 252.8 0.175 -4.0 -5.8 -13.2 
EPC:CS:Chol 10:3:7 15.0 229.2 0.181 -4.1 -8.6 -14.7 
EPC:CS:Chol 2:1:1 25.0 185.3 0.103 -4.5 -12.8 -18.5 
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 Graph 2 EPC:CS:Chol - liposomes, zeta potential 
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Extrusions through the 200 nm-pored membrane produced liposomes of widely 
varying sizes: 196.4 nm (5% CS), 252.8 nm (10% CS), 229.2 nm (15% CS), and 185.3 nm 
(25% CS). In this case, no gradual shrinking of liposome sizes can be seen, unlike the 
liposomes with SA. Theoretically, such shrinking should still be taking place, but 
subsequent investigations suggested that not all CS is built into the liposomal 
membrane. Some CS is apparently bound, due to its negative charge, only to the 
surface of the liposome. This would also explain larger sizes and polydispersity of 
liposomes with 10 and 15 per cent content of CS. It is very likely that the reduction of 
size in the formulation with more than 10% CS is caused by the building of mixed 
micelles, which are in the size around 30 nm. 
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The measurements of zeta potential confirmed that the negative charge of CS also 
affects the zeta potential of the liposomes in whose membrane it is caught. The 
constant value around –4 mV measured in PBS even at rising CS content might be a 
result of the zeta potential of the liposomes being suppressed by the relatively strong 
buffer with high ion concentration. In contrast, measurements in both PTP and water 
confirmed that increasing content of negatively charged CS raises the negative charge 
of the liposomes up to -12.8 mV in PTP and -18.5 mV in water (both at 25% CS). Again, 
it was impossible to prepare liposomes with CS content higher than 25% through 
manual extrusion. 
Negative zeta potential of liposomes containing bile acids, in particular the deoxycholic 
acid (DA), was also shown by Fang and others [41]. For liposomes containing EPC, Chol 
and 5% of DA, they measured a zeta potential of -18.3 mV. They also confirmed that 
the zeta potential is to a large extent dependent on the composition of the liposomal 
membrane. For liposomes containing beside EPC and Chol also 5% diacetyl phosphate 
(DP), which is negatively charged, they measured the zeta potential -66.0 mV, for 
liposomes containing EPC, Chol and 5% SA the zeta potential 68.6 mV. However, 
authors did not indicate the pH and buffer of the measurements. Studies of the zeta 
potential of liposomes containing CS are unfortunately not available. 
 
4.3 EPC:TPGS:Chol – liposomes 
 
Table 4 EPC:TPGS:Chol - liposomes, results 
Liposomes TPGS [%] Z ave [nm] Poly 
Zeta [mV] 
in PBS in PTP in H2O 
EPC:Chol 1:1 0.0 274.6 0.117 -3.9 -8.6 -10.4 
EPC:TPGS:Chol 10:1:9 5.0 190.7 0.079 -3.4 -3.2 -6.1 
EPA:TPGS:Chol 5:1:4 10.0 190.9 0.058 -2.5 -2.9 -5.9 
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Graph 3 EPC:TPGS:Chol - liposomes, zeta potential
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Extrusions through the 200 nm-pored membrane produced liposomes with TPGS of 
the sizes 190.7 nm (5% TPGS) and 190.9 nm (10% TPGS). We thus succeeded in 
producing liposomes with size almost equivalent to the pores of the membrane. This 
confirmed the assumption that incorporation of TGPS to the membrane of the 
liposomes affects their size, making them usually smaller than liposome containing 
only EPC and Chol. The first probable cause is the decreasing amount of Chol, 
translating into decreasing fluidity of the liposomal membrane. The second is, that the 
PEG part of the TPGS is rather big and forms a layer around the liposomal membrane 
itself. As the refractive index of the PEG is pretty close to that of water, it might be 
hard to see in the PCS. This is may be another reason, why the TPGS reduces the size of 
the liposomes. Using TGPS, strongly monodisperse populations of liposomes were 
successfully prepared, as attested by low values of polydispersity (0.079 and 0.058, 
respectively). 
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TPGS is an amphiphilic substance, a nonionic surfactant consisting of a lipophilic chain 
of tocopherol succinate and a polar chain of polyethylene glycol (PEG). PEG is not built 
into the liposomal membrane, it stretches into the surrounding space, increasing 
friction at the liposome surface. This also enlarges the Stern layer of charges firmly 
bound to the liposome surface, shifting it towards the solution. All this decreases the 
zeta potential. The values measured in PBS were –3.4 mV (5% TPGS) and –2.5 mV (10% 
TPGS), those in PTP were –3.2 mV and –2.9 mV, and in water –6.1 mV and –5.9 mV, 
respectively. All these zeta potential values are lower than the values of TPGS-free 
liposomes under the same conditions.  
TPGS has only been used in liposome preparation for a short time and no remarks 
about its influence on zeta potential could be found in the literature. On the other 
hand, Yoshioka [42] proved that PEG bound to a phospholipid or cholesterol affects 
the value of zeta potential. The longer the chain of the PEG used, the more the 
liposomal zeta potential dropped.  
Different effects of PEG on zeta potential were shown by Arnold and others [43]. If PEG 
is only contained in the solution and not directly bound to the liposomal membrane, it 
raises markedly the value of the zeta potential. If, on the other hand, it is bound 
directly to the liposome surface via a surfactant built into the liposomal membrane, 
friction at the surface of the liposome increases and the zeta potential falls. 
 
4.4 EPC:TPGS:SA:Chol and EPC:TPGS:CS:Chol – liposomes 
In all of these cases, the liposomes prepared contained 5% TPGS.  
 
Table 5 EPC:TPGS:SA:Chol - liposomes, results 
Liposomes SA [%] Z ave [nm] Poly 
Zeta [mV] 
in PBS in PTP in H2O 
EPC:TPGS:Chol 10:1:9 0.0 190.7 0.079 -3.4 -3.2 -6.1 
EPC:TPGS:SA:Chol 10:1:2:7 10.0 175.6 0.096 4.2 25.0 34.6 
EPA:TPGS:SA:Chol 10:1:4:5 20.0 140.3 0.154 6.0 21.7 36.5 
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Graph 4 EPC:TPGS:SA:Chol - liposomes, zeta potential 
Zetapotential of EPC:TPGS:SA:Chol - liposomes
2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5
-10
0
10
20
30
40
Zeta in H2O [mV]
Zeta in PBS [mV]
Zeta in PTP [mV]
Quantity of SA [%]
Z
et
a 
[m
V
]
 
Measurements again confirmed that adding SA to the liposomes reduces their size due 
to the positive charge of SA. For liposomes containing beside EPC and Chol also 5% of 
TPGS and 10% or 20% of SA, average sizes were 175.6 nm and 140.3 nm, respectively. 
The positive charge of SA influenced the zeta potential, which reached positive values 
in all three buffers, namely 6.0 mV in PBS (20% SA), 25.0 mV in PTP (10% SA), and 36.5 
mV in water (20% SA). 
Similar results were obtained for liposomes of the EPC:TPGS:CS:Chol formula.  
 
Table 6 EPC:TPGS:CS:Chol - liposomes, results 
Liposomes CS [%] Z ave [nm] Poly 
Zeta [mV] 
in PBS in PTP in H2O 
EPC:TPGS:Chol 10:1:9 0.0 190.7 0.079 -3.4 -3.2 -6.1 
EPC:TPGS:CS:Chol 10:1:2:7 10.0 167.1 0.075 -4.4 -4.4 -10.5 
EPA:TPGS:CS:Chol 10:1:4:5 20.0 179.7 0.077 -3.0 -5.7 -13.9 
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Graph 5 EPC:TPGS:CS:Chol - liposomes, zeta potential 
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It was confirmed in these cases, too, that adding CS to liposomes causes their size to 
shrink. Just as with liposomes only containing EPC, CS and Chol, here too the shrinking 
was not gradual as could be expected according to theory. It was again not possible to 
clarify whether this was due to a part of CS not built directly into the liposomal 
membrane but instead only bound by its negative charge to the surface of the 
liposome. Using PCS, the average sizes of liposomes measured were 167.1 nm (10% CS) 
and 179.7 nm (20% CS). The negative charge of CS also manifested itself in the values 
of zeta potential, which shifted to negative territory in contrast to CS-free liposomes. 
Values as negative as -5.7 mV in PTP (20% CS) and –13.9 mV in water (20% CS) were 
measured. Paradoxical values were obtained from measurements in PBS. The zeta 
potential of liposomes containing only EPC, 5% TPGS and Chol measured in this buffer 
was –3.4 mV. Adding 10% CS changed the value to –4.4 mV, whereas liposomes with 
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20% CS exhibited zeta potential of only –3.0 mV. We can again only speculate that a 
part of the CS was only bound to the surface of the liposomes by its negative charge, 
which was however suppressed by the buffer (similarly to liposomes only containing 
EPC, CS and Chol), thus making the role of PEG more prominent. The CS has under the 
chosen conditions no influence on the potential.  
The impact of TPGS, or rather its hydrophilic part PEG, on the zeta potential of 
liposomes containing EPC, TPGS, Chol and SA vs. EPC, TPGS, Chol and CS can best be 
demonstrated by comparison of the zeta potential of these liposomes with liposomes 
containing EPC, SA, Chol and PC, CS, Chol with the same amount of SA and CS (i.e. 0, 
10, and 20%). 
Graph 6 EPC:SA:Chol – liposomes with and without TPGS, comparision of zeta potentials  
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Graph 7 EPC:CS:Chol - liposomes with and without TPGS, comparision of zeta potentials 
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Similar to liposomes only containing EPC, TPGS and Chol, in this case as well PEG 
suppressed the zeta potential. PEG masks, so to speak, the zeta potential caused by 
the charge of SA or CS. This corroborates the conclusions reached in the studies of 
Yoshioka and Arnold and others (see 4.3 EPC:TPGS:Chol – liposomes). 
 
4.5 EPC:SA:CS:Chol – liposomes 
 
Table 7 EPC:SA:CS:Chol - liposomes, results 
Liposomes SA [%] CS [%] 
Z ave 
[nm] 
Poly 
Zeta [mV] 
in PBS in PTP in H2O 
EPC:SA:CS:Chol 10:4:1:5 20.0 5.0 155.8 0.198 25.5 42.5 55.2 
EPC:SA:CS:Chol 5:2:1:2 20.0 10.0 151.1 0.122 26.3 34.3 44.4 
EPA:SA:CS:Chol 10:1:2:7 5.0 10.0 190.6 0.088 7.5 19.8 27.4 
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Graph 8 EPC:SA:CS:Chol - liposomes, zeta potential 
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Extrusions through the 200 nm-pored membrane produced liposomes with sizes of 
155.8 nm (20% SA, 5% CS), 151.1 nm (20% SA, 10% CS) and 190.6 nm (5% SA, 10% CS). 
Presence of SA and CS again affected the size of the liposome, liposomes with higher 
amounts of SA and CS being much smaller than liposomes with higher amount of Chol 
at the expense of SA and CS. This is because Chol increases fluidity of the membrane, 
which then produces larger liposomes.  
Zeta potential measurements showed that SA can balance the negative charge of CS, 
even to the extent of completely covering it. Positive zeta potential was measured in 
all buffers, although the last group of liposomes contained higher amount of the 
negatively charged CS (10%) than of the positively charged SA (5%). This shows that it 
is possible to prepare liposomes with a positive zeta potential containing negatively 
charged substances in their membranes, such as bile acids, that increase permeability 
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of liposomes through biological membranes. Small amounts of SA are sufficient to 
achieve a positive zeta potential, which is welcome as it is relatively highly toxic.  
Unfortunately, no literature was found dealing with joint applications of bile acids and 
cationic lipids in liposomes and their impact on zeta potential. These conclusions thus 
cannot be compared with results of other studies.  
 
4.6 Influence of pH on zeta potential 
Another problem worth notice is the impact of different pH on the zeta potential of 
identical liposomes. Measurements were carried out in PTP with pH set at 5.0, 7.0 and 
8.4, respectively. 
 
Table 8 pH - dependent zeta potential, results 
Liposomes 
Zeta [mV] in PTP 
pH 5.0 pH 7.0 pH 8.4 
EPC:Chol 1:1 -1.2 -8.6 -16.2 
EPC:SA:Chol 5:1:4 44.1 37.8 11.2 
EPC:CS:Chol 5:1:4 -16.6 -14.8 -24.1 
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Graph 9 pH - dependent zeta potential, in PTP 
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The influence of pH on zeta potential was observed with three different liposome 
types. It was possible to confirm that an acid pH shifts the zeta potential towards 
positive values and, conversely, a basic pH shifts the zeta potential towards negative 
values. Values measured for the liposomes EPC:Chol (1:1) were –1.2 mV (pH 5.0), -8.6 
mV (pH 7.0), and –16.2 mV (pH 8.4). For the liposomes EPC:SA:Chol (5:1:4), zeta 
potential was 44.1 mV (pH 5.0), 37.8 mV (pH 7.0), and 11.2 mV (pH 8.4). Only 
liposomes of the composition EPC:CS:Chol (5:1:4) produced results at odds with the 
hypothesis. Zeta potential was more negative at pH 5.0 (-16.6 mV) than at pH 7.0  
(-14.8 mV). At pH 8.4, the most negative value was measured as expected –24.1 mV. It 
can only be speculated whether this was again the influence of CS not being built into 
the liposomal membrane. 
The hypothesis that acid pH shifts zeta potential towards positive values and basic 
towards negative values was also confirmed by Son and others [44], who studied 
changes of zeta potential of liposome/DNA complexes under changes of ionic strength 
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and pH. They reached this conclusion for complexes of both positive and negative zeta 
potential. 
Svensson and others [45] studied the impact of pH on electrophoretic mobility and 
zeta potential for liposomes whose surface was modified by chitosane. For these 
particles, the zeta potential they measured at pH 3 was 16.0 mV against -7.0 mV at pH 
8. The pH value was also important for interactions of these liposomes with mucine.     
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5 CONCLUSIONS 
During the experimental stage of this work, it was achieved by manual extrusion to 
prepare liposomes of varying size, thus proving the presupposition that the liposome 
size significantly depends on its membrane composition. Higher cholesterol rate 
increases the fluidity of liposomal membrane, which causes formation of liposomes 
bigger than the membrane pores of the extruder; on the contrary stearylamine and 
cholylsarcosine cause smaller liposome size by their charges. TPGS also causes smaller 
size of liposomes, probably because of its PEG chains which increase liposome stability, 
inhibiting their aggregation, and so the liposomes may look smaller on the PCS. 
It was achieved to prove the influence of SA, CS and TPGS on liposome zeta potential 
as well. SA with its positive charge induces positive zeta potential in liposomes, already 
in very small concentrations. Similarly, CS with its negative charge induces negative 
zeta potential. In liposomes containing both SA and CS, SA suppresses the negative 
charge of CS and so these liposomes show positive zeta potential. That is a particularly 
important discovery because it proves the possibility of preparing liposomes with a 
small amount of SA (5%) that show positive zeta potential together with the 
favourable features of CS (the ability to form complexes with cations, thus improving 
their absorption). Liposomes with positive zeta potential have far broader application 
in use; furthermore they are not taken up so fast by cells of reticuloendothelial system. 
TPGS causes reduction of zeta potential; it is possible to say that it disguises it. This is 
caused mainly by PEG chains which push the border of the Stern layer into the 
exterior, causing the measured zeta potential to be lower than in equal liposomes 
without PEG. 
The next issue of this project was the influence of pH on zeta potential as zeta 
potential is an important indicator of liposome stability and pH changes rapidly in the 
gastrointestinal tract after administration by mouth. As expected, it was proved that 
an acid pH shifts liposome zeta potential towards positive values and basic pH towards 
negative values. 
It could be shown that the researched substances, which have been used in this field 
only recently and rarely, are applicable in liposome preparation. With them it is 
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possible to achieve such surface properties as with commonly used phospholipids or 
bile acids, and some of their qualities are even better (e.g. lower toxicity of CS 
compared to bile acids [30]). A significant advantage is also their lower price which 
could become an important criterion for choosing them. 
In studying the surface properties of liposomes prepared this way, we have made only 
the first step. The whole research should lead towards administrating peptide drugs 
(e.g. insulin or calcitonin) by mouth, liposomes serving as their protective sheath which 
also improve their absorption from the gastrointestinal tract. The next goal could 
therefore be studying interactions between those liposomes and biological 
membranes, first on artificial membranes with defined pore size and then on model 
cell membranes. Another step would be examining the liposomes’ stability and the 
amount of drugs they are able to hold inside. It is also necessary to research 
possibilities of transforming the liposomes into a stable form, because freshly 
prepared liposomes stored only in buffers eventually succumb to degradation. This can 
be avoided by freeze drying; after that, the liposomes can be reconstituted by adding a 
suitable buffer or dissolvent in which they would be given to patients. Or it is also 
desirable to encapsulate the dried liposomes in capsules and to apply those capsules 
orally to the patient. Further research could look into conditions of freeze drying and 
consequent changes in the liposomes and drugs contained inside them. 
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6 SOUHRN 
Perorální podání je nejpohodlnější aplikace léčiv. Již několik let probíhají mnohé 
výzkumy jak podávat perorálně například inzulín nebo kalcitonin. Bohužel mnohé látky, 
zejména bílkovinné nebo peptidické povahy, nejsou schopny vydržet agresivní 
podmínky, které se vyskytují v trávicí soustavě (GIT), jako je velmi rozdílné pH, 
působení kyselin nebo trávicích enzymů. Dochází tak k jejich degradaci ještě dříve, než 
se vůbec mohou vstřebat a začít terapeuticky působit. Tyto látky se kvůli velikosti své 
molekuly nebo náboji často ani nevstřebávají. Vyvstává tedy potřeba tyto látky chránit 
a zlepšit jejich absorpci. A jako vhodnými kandidáty na tuto funkci se jeví lipozómy. 
Lipozómy jsou částice s fosfolipidovou dvouvrstevnou membránou, kterou lze připravit 
nejen ze široké škály fosfolipidů, ale i z mnohých povrchově aktivních látek a solí 
žlučových kyselin. Díky tomu lze připravit lipozómy s velmi různorodými vlastnostmi, 
které na složení membrány do jisté míry závisí, velikostí, povrchovým nábojem (zeta 
potenciálem), s různým charakterem povrchových skupin. Různé lipozómy mají i po 
podání do organismu různý osud, některé jsou rychleji vychytávány buňkami 
retikuloendoteliárního systému, některé jsou prioritně vychytávány mozkovými 
buňkami, jiné lépe pronikají střevní stěnou. Pro perorální podání je zvláště důležitá 
odolnost vůči agresivním podmínkám GIT a schopnost difundovat nebo se vstřebávat 
do střevní stěny. Tyto vlastnosti bohužel mnohé lipozómy nemají, spíše naopak, i 
lipozómy jsou v GIT často degradovány dříve, než dosáhnou svého cíle, proto neustále 
probíhá výzkum nových i známých kombinací již tradičních surovin, či se zkouší látky 
úplně nové.  
Cílem této práce bylo připravit lipozómy s přídavkem v praxi zřídka používaných 
surovin, konkrétně cholylsarkosinu (CS), stearylaminu (SA) a d-α-
tokoferolsukcinátu(TPGS), a zjistit některé jejich povrchové vlastnosti, které jsou 
rozhodující pro další použití lipozómů. Připravené lipozómy vždy obsahovaly 
fosfatidylcholin z vaječného bílku (EPC), cholesterol (Chol) a jednu nebo více výše 
uvedenou zkoumanou substanci. Naměřené údaje byly porovnávány s výsledky 
získanými za stejných podmínek u lipozómů o složení EPC:Chol (1:1). 
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Lipozómy byly připravovány filmovou metodou a následnou hydratací a ruční extruzí 
přes membránu s definovanou velikostí pórů 200 nm. Dále byla měřena jejich velikost 
a polydisperzita a nakonec zeta potenciál ve dvou pufrech a v destilované vodě.  
Velikost lipozómů byla měřena pomocí Zetasizeru 3000 HS (Malvern). Při tomto měření 
byla navíc získávána i polydisperzita, která vypovídá o šíři distribuce velikosti lipozómů. 
Dále bylo pracováno pouze se vzorky, jejichž polydisperzita byla menší než 0,2. Velikost 
lipozómů závisí především na použitých substancích, na jejich náboji nebo rigiditě 
molekuly, dále na velikosti pórů membrány použité při extruzi, iontové síle použitého 
média a povrchové struktuře lipozómů.    
U lipozómů složených pouze z EPC a Chol byla naměřena průměrná velikost 274,6 nm. 
Všechny ostatní lipozómy se vykazovaly velikostí menší, konkrétně u lipozómů se SA 
byla naměřena velikost až 187,3 nm (EPC:SA:Chol 2:1:1), s CS 185,3 nm (EPC:CS:Chol 
2:1:1), s TPGS 190,7 nm (EPC:TPGS:Chol 10:1:9). Stejný trend se projevil i u lipozómů 
s kombinací čtyř substancí, opět konkrétně 140,3 nm (EPC:TPGS:SA:Chol 10:1:4:5), 
167,1 nm (EPC:TPGS:CS:Chol 10:1:2:7) a 151,1 nm (EPC:SA:CS:Chol 5:2:1:2). Velkou 
velikost lipozómů, jejichž membrána byla pouze z EPC a Chol, lze považovat za 
důsledek poměrně velkého obsahu Chol, který zvyšuje fluiditu lipozomální membrány a 
při extruzi tak vznikají lipozómy větší. Zmenšující se velikost po přidání různých 
substancí má různá vysvětlení. Jedním, společným pro všechny případy, je fakt, že 
složení lipozomální membrány se měnilo vždy na úkor Chol. Ve všech lipozómech byl 
stále stejný podíl EPC, ale podíl Chol vždy klesal se vzrůstajícím množstvím přidávané 
zkoušené substance. Tím tedy i klesala fluidita lipozomální membrány a extruzí byly 
získávány lipozómy o menší velikosti. I zkoušené látky ale působily na velikost lipozómů 
svými vlastnostmi. SA a CS nesou náboj, SA kladný, CS záporný. Tento náboj se 
projevuje i na lipozomálním povrchu, lipozómy se pak navzájem odpuzují, je tak 
zabráněno jejich agregaci a na PCS se mohou jevit jako menší.  Součástí molekuly TPGS 
je polyethylenglykol (PEG), který je v ní vázán esterovou vazbou. Je – li molekula TPGS 
zabudována do lipozomální membrány, řetězce PEG trčí ven směrem do rozpouštědla, 
čímž se molekula na PCS může jevit jako větší, neboť se tak snižuje její hybnost. PEG 
také zabraňuje agregaci lipozómů. Zmenšení velikosti lipozómů tak nejspíš bude 
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důsledkem sníženého obsahu Chol a antiagregačního působení PEG, které převládají 
nad zvětšujícím efektem PEG vlivem snížení hybnosti lipozómů.  
Další povrchovou vlastností lipozómů, která byla zkoumána, byl zeta potenciál. Zeta 
potenciál je náboj lipozómu, který částice získává ve vodném médiu. Není to ale náboj 
přímo na povrchu lipozómu, ale náboj na povrchu jeho solvatačního obalu, tzv. 
Nernstův potenciál. Závisí na povaze povrchu částice a na vlastnostech média, ve 
kterém je částice dispergována. Měření vždy probíhalo ve dvou fosfátových pufrech a 
v destilované vodě. Fosfátovými pufry byly PBS (Phosphate Salined Buffer) o pH 7,4 a 
PTP (Phosphat-Trennpuffer) o pH 7,0. Zeta potenciál byl měřen pomocí Zetasizeru 
3000 HS (Malvern). Opět byly získané hodnoty porovnávány s výsledky lipozómů o 
složení EPC:Chol 1:1, u kterých byl naměřen zeta potenciál -3,9 mV (v PBS), -8,6 mV (v 
PTP) a -10,4 mV (ve vodě). 
 Zkoumané substance ovlivňovaly svými vlastnostmi i zeta potenciál. SA nese kladný 
náboj, který posunul zeta potenciál do kladných hodnot – konkrétně byly dosaženy až 
hodnoty 38,2 mV (v PBS), 53,3 mv (v PTP) a 57,9 mV (ve vodě). Zeta potenciál postupně 
stoupal se stoupajícím obsahem SA v lipozómech.  Při vyšších koncentracích SA (nad 20 
mol%) ale dochází k nasycení zeta potenciálu, se zvyšujícím se podílem SA se hodnota 
zeta potenciálu již příliš nemění. 
CS je sůl žlučové kyseliny, nese záporný náboj a zeta potenciál posouvá do hodnot 
záporných. Teoreticky by se zeta potenciál měl postupně snižovat se zvyšujícím se 
podílem CS (obdobně jako u SA), ale naměřené hodnoty tomuto předpokladu úplně 
neodpovídaly. V průběhu dalších měření se objevil problém, že se zřejmě jen část CS 
váže do lipozomální membrány a část je navázána na povrchu lipozómů jen díky svému 
náboji. To by mohlo vysvětlovat vlnovitý tvar křivky závislosti zeta potenciálu na 
množství CS v lipozómech. Tuto hypotézu se ale v průběhu experimentální části této 
práce již nepodařilo potvrdit ani vyvrátit. Jako nepříliš vhodný pro měření zeta 
potenciálu u lipozómů s CS se ukázal PBS, což je pufr poměrně silný a zřejmě dokázal 
náboj CS potlačit. V PBS byla naměřena největší hodnota zeta potenciálu pouze -4,5 
mV. V ostatních médiích byly naměřeny největší hodnoty zeta potenciálu -12,8 mV (v 
PTP) a -18,5 mV (ve vodě).  
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TPGS také ovlivňuje zeta potenciál. Hlavně jeho řetězec z PEG. Ten není zabudován do 
lipozomální membrány, trčí z ní ven do rozpouštědla a posouvá hranici Sternovy vrstvy 
směrem od lipozómu. To vede ke zmenšení zeta potenciálu. U lipozómů s TPGS tedy 
byly naměřeny hodnoty zeta potenciálu -2,5 mV (v PBS), - 2,9 mV (v PTP) a -5,9 mV (ve 
vodě). Podobně se vliv TPGS na zeta potenciál projevil i u lipozómů, jejichž membrána 
byla složena ze EPC, Chol, TPGS a SA nebo CS. Bylo připraveno několik druhů lipozómů, 
které vždy obsahovaly 50 mol% EPC, 5 mol% TPGS a proměnlivý obsah Chol a SA nebo 
CS. U všech vzorků byl naměřený zeta potenciál menší než zeta potenciál lipozómů bez 
TPGS, které jinak měly stejné složení membrány a byly měřeny ve stejných pufrech za 
stejných podmínek. Dá se tedy říci, že TPGS zeta potenciál lipozómů maskuje.  
Dalším zkoumaným problémem byl vliv SA a CS, které byly společně v lipozomální 
membráně. Měření zeta potenciálu ukázalo, že SA je schopen vyvažovat negativní 
náboj CS, dokonce jej i úplně zakrýt. Ve všech pufrech byl naměřen kladný zeta 
potenciál, i když poslední připravená skupina lipozómů obsahovala větší podíl 
negativně nabitého CS (10%) než podíl kladně nabitého SA (5%). Ukázalo se tedy, že lze 
připravovat lipozómy s kladným zeta potenciálem, které ve své membráně obsahují 
např. negativně nabité soli žlučových kyselin, které zvyšují prostupnost lipozómů skrz 
biologické membrány. Na dosažení kladného zeta potenciálu navíc stačí velmi málo SA, 
což je důležité zjištění vzhledem k jeho poměrně vysoké toxicitě. 
Dalším problémem, který stál za povšimnutí, byl vliv různého pH na zeta potenciál 
stejných lipozómů. Měření bylo prováděno v PTP, jehož pH bylo upraveno na hodnoty 
5,0; 7,0 a 8,4. Byl pozorován vliv pH na zeta potenciál u tří různých druhů lipozómů. 
Podařilo se potvrdit, že kyselé pH posouvá zeta potenciál do kladnějších hodnot a 
naopak zásadité pH posouvá zeta potenciál k hodnotám záporným. Konkrétně u 
lipozómů o složení EPC:Chol (1:1) byly naměřeny hodnoty -1,2 mV (pH 5,0), -8,6 mV 
(pH 7,0) a -16,2 mV (pH 8,4). U lipozómů EPC:SA:Chol (5:1:4) pak 44,1 mV (pH 5,0), 
37,8 mV (pH 7,0) a 11,2 mV (pH 8,4). Pouze lipozómy o složení EPC:CS:Chol (5:1:4) 
poskytly výsledky, které daný předpoklad nepotvrdily. Zeta potenciál při pH 5,0 byl 
zapornější (-16,6 mV) než zeta potenciál při pH 7,0 (-14,8 mV). Při pH 8,4 ale byla 
naměřena očekávaná nejzápornější hodnota -24,1 mV. Zda se opět projevil vliv CS, 
který nebyl zabudován do lipozomální membrány, lze pouze spekulovat. 
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Podařilo se tedy prokázat, že zkoumané substance, které se v této oblasti používají 
poměrně řídce a krátkou dobu, jsou vhodné k přípravě lipozómů. Lze s nimi dosáhnout 
takových povrchových vlastností, které vykazují tradičně používané fosfolipidy nebo 
žlučové kyseliny, mnohdy je svými vlastnostmi i předčí (např. nižší toxicita CS oproti 
klasickým žlučovým kyselinám). Nezanedbatelnou výhodou je i jejich nižší cena, která 
může být v jejich budoucím použití v praxi jedním z důležitých kritérií pro jejich volbu. 
K perorálnímu podání bílkovinných léčiv ale ještě vede dlouhá cesta, na níž bylo touto 
prací uděláno jen pár prvních kroků.  
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